Fundamental Equity Fund
Daily price w/o sales charge as of 02/01/2023
$12.56
$0.11
YTD Returns w/o sales charge as of 02/01/2023
5.63%
Please click here for performance current to the most recent quarter-end and month-end.
Portfolio Details as of 12/30/2022
- Total Net Assets
- $1.95 B
To view definitions for the above Portfolio Details, Click here.
Summary
Summary
Fund Basicsas of 12/30/2022
- Total Net Assets
- $1.95 B
- Inception Date
- 07/15/1996
- Dividend Frequency
- Annually
- Number of Holdings
- 62
- Minimum Initial Investment
- $1,500+
Expense Ratioas of 12/31/2022
Yield
12-Month Dividend Yield 1 as of 02/01/2023
| w/o sales charge | 1.15% |
| w/ sales charge | 1.08% |
30-Day Standardized Yield 2 as of 12/31/2022 |
0.84% |
Fund Expense Ratio :
0.96%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 07/15/1996 |
|---|
| w/o sales charge | 4.71% | -2.29% | 8.92% | 6.16% | 9.34% | 9.45% |
| Lipper Category Avg. Multi-Cap Value Funds | - | - | - | - | - | - |
| Russell 1000® Value Index | 5.18% | -0.43% | 8.54% | 6.94% | 10.15% | 8.93% |
| w/ sales charge | -1.35% | -7.92% | 6.79% | 4.91% | 8.69% | 9.21% |
Performance data for the Lipper Category Average and for the Index is shown as soon as it becomes available.
Fund Expense Ratio :
0.96%
Fund Expense Ratio :
0.96%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 07/15/1996 |
|---|
| w/o sales charge | -9.45% | -9.45% | 6.24% | 6.15% | 9.57% | 9.29% |
| Lipper Category Avg. Multi-Cap Value Funds | -6.79% | -6.79% | 6.89% | 6.69% | 9.99% | - |
| Russell 1000® Value Index | -7.54% | -7.54% | 5.96% | 6.67% | 10.29% | 8.76% |
| w/ sales charge | -14.64% | -14.64% | 4.16% | 4.90% | 8.92% | 9.05% |
Fund Expense Ratio :
0.96%
Returns with sales charges reflect a maximum sales charge of 5.75%.
The performance quoted represents past performance, which is no indication of future results. Current performance may be higher or lower than the performance data quoted. Returns shown include the reinvestment of all distributions. Returns shown at net asset value do not reflect the current maximum sales charge, had the sales charge been included, returns would have been lower. The investment return and principal value of an investment will fluctuate so that shares, on any given day or when redeemed, may be worth more or less than the original cost. Therefore, there can be no assurance for future results.
TEN LARGEST HOLDINGS as of 12/30/2022View Portfolio
| Holding | Assets |
|---|---|
| Pfizer Inc | 3.0% |
| UnitedHealth Group Inc | 2.9% |
| Raytheon Technologies Corp | 2.8% |
| JPMorgan Chase & Co | 2.7% |
| Procter & Gamble Co/The | 2.5% |
| Schlumberger Ltd | 2.4% |
| Shell PLC | 2.3% |
| AbbVie Inc | 2.2% |
| Allstate Corp/The | 2.2% |
| Ameriprise Financial Inc | 2.2% |
Aggregate holdings are updated monthly, 30 days after month end. Aggregate holdings are presented to illustrate examples of the securities that the Fund has bought and the diversity of the areas in which the Fund may invest, and may not be representative of the Fund's current or future investments. The figures presented are as of the date shown and may change at any time.
Sector Allocationas of 12/30/2022View Portfolio
| Sector | Weighting |
|---|
| Sector | Weighting |
|---|---|
| Communication Services | |
| Real Estate | |
| Utilities | |
| Consumer Discretionary | |
| Consumer Staples | |
| Energy | |
| Financials | |
| Health Care | |
| Industrials | |
| Information Technology | |
| Materials |
INVESTMENT TEAM
Your Representative
To contact your representative, enter your zip code and select your channel below.
Performance
Performance
12-Month Dividend Yield 1 as of 02/01/2023
| w/o sales charge | 1.15% |
| w/ sales charge | 1.08% |
30-Day Standardized Yield 2 as of 12/31/2022
| Subsidized5 | Un-Subsidized6 | |
|---|---|---|
| w/o sales charge | 0.84% | 0.84% |
In absence of the fee waiver, yields shown would have been lower. Yields for other share classes will vary.
Fund Expense Ratio :
0.96%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 07/15/1996 |
|---|
| w/o sales charge | 4.71% | -2.29% | 8.92% | 6.16% | 9.34% | 9.45% |
| Lipper Category Avg. Multi-Cap Value Funds | - | - | - | - | - | - |
| Russell 1000® Value Index | 5.18% | -0.43% | 8.54% | 6.94% | 10.15% | 8.93% |
| w/ sales charge | -1.35% | -7.92% | 6.79% | 4.91% | 8.69% | 9.21% |
Performance data for the Lipper Category Average and for the Index is shown as soon as it becomes available.
Fund Expense Ratio :
0.96%
Fund Expense Ratio :
0.96%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 07/15/1996 |
|---|
| w/o sales charge | -9.45% | -9.45% | 6.24% | 6.15% | 9.57% | 9.29% |
| Lipper Category Avg. Multi-Cap Value Funds | -6.79% | -6.79% | 6.89% | 6.69% | 9.99% | - |
| Russell 1000® Value Index | -7.54% | -7.54% | 5.96% | 6.67% | 10.29% | 8.76% |
| w/ sales charge | -14.64% | -14.64% | 4.16% | 4.90% | 8.92% | 9.05% |
Fund Expense Ratio :
0.96%
Returns with sales charges reflect a maximum sales charge of 5.75%.
The performance quoted represents past performance, which is no indication of future results. Current performance may be higher or lower than the performance data quoted. Returns shown include the reinvestment of all distributions. Returns shown at net asset value do not reflect the current maximum sales charge, had the sales charge been included, returns would have been lower. The investment return and principal value of an investment will fluctuate so that shares, on any given day or when redeemed, may be worth more or less than the original cost. Therefore, there can be no assurance for future results.
| Year | Fund Returns | Russell 1000® Value Index |
|---|
| 2022 | -9.45% | -7.54% |
| 2021 | 29.02% | 25.16% |
| 2020 | 2.64% | 2.80% |
| 2019 | 22.76% | 26.54% |
| 2018 | -8.45% | -8.27% |
| 2017 | 12.97% | 13.66% |
| 2016 | 15.74% | 17.34% |
| 2015 | -3.14% | -3.83% |
| 2014 | 6.93% | 13.45% |
| 2013 | 36.63% | 32.53% |
| 2012 | 10.74% | - |
| 2011 | -3.92% | - |
| 2010 | 19.21% | - |
| 2009 | 25.86% | - |
| 2008 | -28.75% | - |
| 2007 | 7.48% | - |
| 2006 | 13.64% | - |
| 2005 | 5.48% | - |
| 2004 | 15.61% | - |
| 2003 | 31.93% | - |
| Year | Q1 | Q2 | Q3 | Q4 | Yearly Returns |
|---|
| 2023 | - | - | - | - | 5.63% |
| 2022 | -2.46% | -13.49% | -4.03% | 11.81% | -9.45% |
| 2021 | 10.44% | 5.10% | 1.43% | 9.59% | 29.02% |
| 2020 | -26.90% | 16.57% | 4.31% | 15.47% | 2.64% |
| 2019 | 10.90% | 2.16% | 1.96% | 6.27% | 22.76% |
| 2018 | -2.47% | -0.55% | 6.29% | -11.19% | -8.45% |
| 2017 | 1.55% | 2.21% | 3.13% | 5.54% | 12.97% |
| 2016 | -0.42% | 4.69% | 3.83% | 6.93% | 15.74% |
| 2015 | -0.45% | 0.82% | -8.73% | 5.73% | -3.14% |
| 2014 | 0.20% | 2.87% | 0.00% | 3.74% | 6.93% |
| 2013 | 13.37% | 3.49% | 6.15% | 9.70% | 36.63% |
| 2012 | 11.31% | -6.90% | 5.18% | 1.59% | 10.74% |
| 2011 | 6.50% | -0.94% | -19.59% | 13.26% | -3.92% |
| 2010 | 6.44% | -10.72% | 10.55% | 13.47% | 19.21% |
| 2009 | -8.56% | 12.91% | 16.14% | 4.96% | 25.86% |
| 2008 | -7.52% | 1.24% | -8.38% | -16.94% | -28.75% |
| 2007 | 2.19% | 5.79% | 2.10% | -2.62% | 7.48% |
| 2006 | 7.63% | -0.24% | 1.18% | 4.59% | 13.64% |
| 2005 | -2.00% | -0.17% | 5.87% | 1.84% | 5.48% |
| 2004 | 3.22% | 1.38% | -0.36% | 10.88% | 15.61% |
| 2003 | -3.21% | 15.84% | 2.98% | 14.27% | 31.93% |
| 2002 | 3.62% | -8.89% | -14.47% | 6.00% | -14.41% |
| 2001 | -7.84% | 5.38% | -8.91% | 8.29% | -4.20% |
| 2000 | -1.63% | -2.39% | 6.22% | 7.14% | 9.27% |
| 1999 | 3.62% | 10.89% | -6.04% | 11.41% | 20.29% |
| 1998 | 10.30% | -0.68% | -11.22% | 18.71% | 15.47% |
| 1997 | 1.97% | 14.32% | 6.43% | 2.93% | 27.70% |
| 1996 | - | - | - | 8.70% | 18.60% |
Performance is shown for each quarter and each calendar year. Past performance is no guarantee of future results.
NAV HISTORICAL PRICES
| Date | Net Asset Value |
|---|
Portfolio
Portfolio
| Holding | Sector | Assets |
|---|
| Pfizer Inc | Health Care | 3.0% |
| UnitedHealth Group Inc | Health Care | 2.9% |
| Raytheon Technologies Corp | Industrials | 2.8% |
| JPMorgan Chase & Co | Financials | 2.7% |
| Procter & Gamble Co/The | Consumer Staples | 2.5% |
| Schlumberger Ltd | Energy | 2.4% |
| Shell PLC | Energy | 2.3% |
| AbbVie Inc | Health Care | 2.2% |
| Allstate Corp/The | Financials | 2.2% |
| Ameriprise Financial Inc | Financials | 2.2% |
Aggregate holdings are updated monthly, 30 days after month end. Aggregate holdings are presented to illustrate examples of the securities that the Fund has bought and the diversity of the areas in which the Fund may invest, and may not be representative of the Fund's current or future investments. The figures presented are as of the date shown and may change at any time.
| Holding | Sector | Assets |
|---|
| Pfizer Inc | Health Care | 3.0% |
| UnitedHealth Group Inc | Health Care | 2.9% |
| Raytheon Technologies Corp | Industrials | 2.8% |
| JPMorgan Chase & Co | Financials | 2.7% |
| Procter & Gamble Co/The | Consumer Staples | 2.5% |
| Schlumberger Ltd | Energy | 2.4% |
| Shell PLC | Energy | 2.3% |
| AbbVie Inc | Health Care | 2.2% |
| Ameriprise Financial Inc | Financials | 2.2% |
| Allstate Corp/The | Financials | 2.2% |
| Organon & Co | Health Care | 2.1% |
| Lockheed Martin Corp | Industrials | 2.0% |
| Chesapeake Energy Corp | Energy | 1.9% |
| AerCap Holdings NV | Industrials | 1.9% |
| Parker-Hannifin Corp | Industrials | 1.9% |
| Pioneer Natural Resources Co | Energy | 1.8% |
| Alphabet Inc | Communication Services | 1.8% |
| Wells Fargo & Co | Financials | 1.8% |
| Charles Schwab Corp/The | Financials | 1.8% |
| EMCOR Group Inc | Industrials | 1.7% |
| BJ's Wholesale Club Holdings Inc | Consumer Staples | 1.7% |
| Microsoft Corp | Information Technology | 1.7% |
| Fiserv Inc | Information Technology | 1.7% |
| T-Mobile US Inc | Communication Services | 1.6% |
| McKesson Corp | Health Care | 1.6% |
| Morgan Stanley | Financials | 1.6% |
| Arthur J Gallagher & Co | Financials | 1.6% |
| Norfolk Southern Corp | Industrials | 1.6% |
| RenaissanceRe Holdings Ltd | Financials | 1.6% |
| Adobe Inc | Information Technology | 1.6% |
| Arch Capital Group Ltd | Financials | 1.6% |
| Valvoline Inc | Materials | 1.5% |
| Target Corp | Consumer Discretionary | 1.5% |
| Thermo Fisher Scientific Inc | Health Care | 1.5% |
| NextEra Energy Inc | Utilities | 1.4% |
| General Motors Co | Consumer Discretionary | 1.4% |
| CVS Health Corp | Health Care | 1.4% |
| Comcast Corp | Communication Services | 1.4% |
| American Express Co | Financials | 1.4% |
| Texas Instruments Inc | Information Technology | 1.3% |
| Prologis Inc | Real Estate | 1.3% |
| Lowe's Cos Inc | Consumer Discretionary | 1.3% |
| NetApp Inc | Information Technology | 1.3% |
| Caesars Entertainment Inc | Consumer Discretionary | 1.2% |
| East West Bancorp Inc | Financials | 1.2% |
| PayPal Holdings Inc | Information Technology | 1.2% |
| Masco Corp | Industrials | 1.2% |
| Teledyne Technologies Inc | Information Technology | 1.2% |
| Eli Lilly & Co | Health Care | 1.1% |
| AutoZone Inc | Consumer Discretionary | 1.1% |
| Avery Dennison Corp | Materials | 1.1% |
| Carlsberg AS | Consumer Staples | 1.1% |
| Micron Technology Inc | Information Technology | 1.0% |
| KLA Corp | Information Technology | 1.0% |
| American Homes 4 Rent | Real Estate | 1.0% |
| KKR & Co Inc | Financials | 1.0% |
| Jacobs Solutions Inc | Industrials | 0.9% |
| NRG Energy Inc | Utilities | 0.9% |
| Reliance Steel & Aluminum Co | Materials | 0.8% |
| Assurant Inc | Financials | 0.8% |
| Dow Inc | Materials | 0.7% |
| Alcoa Corp | Materials | 0.6% |
Aggregate holdings are updated monthly, 30 days after month end. Aggregate holdings are presented to illustrate examples of the securities that the Fund has bought and the diversity of the areas in which the Fund may invest, and may not be representative of the Fund's current or future investments. The figures presented are as of the date shown and may change at any time.
Sector Allocationas of 12/30/2022
| Sector | Weighting | Fund Change from Previous Quarter |
|---|
| Sector | Weighting | Fund Change from Previous Quarter |
|---|---|---|
| Communication Services |
 0.4%
|
|
| Real Estate |
1.3%
|
|
| Utilities |
0.4%
|
|
| Consumer Discretionary |
0.4%
|
|
| Consumer Staples | 0.0% | |
| Energy |
0.1%
|
|
| Financials |
0.5%
|
|
| Health Care | 0.0% | |
| Industrials |
1.0%
|
|
| Information Technology |
0.4%
|
|
| Materials |
0.5%
|
PORTFOLIO DETAILS as of 12/30/2022
- Total Net Assets
- $1.95 B
- Number of Holdings
- 62
- Weighted Average Market Cap.
- 165.5 B
- P/B Ratio
- 2.9x
- P/E Ratio
- 16.1x
To view definitions for the above Portfolio Details, Click here.
Market Capitalization Breakdown - Morningstar separates stock portfolio holdings into five market-capitalization groups: Giant, Large, Mid, Small, and Micro. Of the 5000 largest domestic stocks in their equities database, the top 1% are categorized as Giant, the next 4% are Large, the next 15% are Mid, the next 30% are Small, and the remaining 50% are Micro. Stocks outside of the largest 5000 are also classified as Micro.
Weighted Average Market Cap - The average market capitalization of all companies held in the portfolio with each company weighted according to its percent held in the portfolio. The result is based upon a weighted average of the securities held in the fund.
P/B Ratio - A ratio that helps determine whether a stock is undervalued or overvalued. It is calculated by dividing a stock's price per share by its book value per share. The result is based upon a weighted average of the securities held in the fund.
P/E Ratio - Is the weighted average of each holding's P/E ratio (price of a stock divided by its earnings per share). The result is based upon a weighted average of the securities held in the fund.
Portfolio Turnover - This is a measure of the Fund’s trading activity which is computed by taking the lesser of purchases or sales divided by average monthly market value, excluding short-term investments. The resulting percentage represents the percentage of the portfolio’s holdings that have changed over the past year.
Contributors & Detractors as of 12/30/2022
Contributors
| Holding | Contribution |
|---|---|
| Schlumberger NV | 0.9% |
| JPMorgan Chase & Co. | 0.7% |
| United Technologies Corp. | 0.6% |
| Aercap Holdings Nv | 0.6% |
| Pfizer, Inc. | 0.5% |
Detractors
| Holding | Contribution |
|---|---|
| PayPal Holdings, Inc. | -0.2% |
| NRG Energy, Inc. | -0.2% |
| Bjs Whsl Club Hldgs Inc | -0.2% |
| Alphabet Inc | -0.2% |
| Assurant, Inc. | -0.1% |
% Contribution reflects the effect of the individual stock's performance on the Fund's overall performance for the period. Individual holdings and their effect on Fund performance may change significantly over time. Investors should consider the overall performance of the Fund before making a decision on whether or not to invest in the Fund.
Attribution Analysis
| Fundamental Equity Fund | Benchmark | Variance | |||||
|---|---|---|---|---|---|---|---|
| Sector | Avg. Weight | Base Return | Avg. Weight | Base Return | Stock Selection | Group Weight | Total |
The total base return displayed for the Fund does not capture daily cash flow and trading activity and therefore is subject to reasonable variance from the Fund's actual return. Please refer to Lord Abbett Fundamental Equity Fund Performance Results for the Fund's longer-term returns. The Fund is actively managed and portfolio characteristics, such as individual holdings and sector weightings, may change significantly over time.
Source: Wilshire Attribution Software. GICS sector classification; non-GICS securities classified by Lord Abbett. Sectors may include many industries.
Dividends & Cap Gains
Dividends & Cap Gains
Dividend Payments
- YTD Dividends Paidas of 02/01/2023
- $0
- Dividend Frequency
- Annually
| Record Date | Ex-Dividend Date | Reinvest & Payable Date | Dividend | Reinvest Price |
|---|---|---|---|---|
| 11/21/2022 | 11/22/2022 | 11/22/2022 | $0.14420 | $12.29 |
Upcoming Dividend Payment Dates
This section lists all anticipated income and Capital Gain distribution dates and any actual distributions are subject to adequacy of earnings and must be approved by the Board of Directors/Trustees. Please note that dates are subject to change.
| Record Date | Ex-Dividend Date | Reinvest & Payable Date |
|---|---|---|
| 11/20/2023 | 11/21/2023 | 11/21/2023 |
Capital Gains Distributions
| Record Date | Reinvest & Payable Date | Long-term | Short-term * | Total | Reinvest Price |
|---|---|---|---|---|---|
| 11/21/2022 | 11/22/2022 | $0.5099 | - | $0.5099 | $12.29 |
Taxed as ordinary income
Lord Abbett does not provide tax advice. It is strongly recommended that you discuss the impact of dividends and distributions with your tax advisor.
Fees & Expenses
Fees & Expenses
Sales Charge Schedule as of 02/01/2023
| Sales Charge | Dealer's Concession | Prices at Breakpoint | |
|---|---|---|---|
| Less than $50,000 | 5.75% | 5.00% | $13.33 |
| $50,000 to $99,999 | 4.75% | 4.00% | $13.19 |
| $100,000 to $249,999 | 3.95% | 3.25% | $13.08 |
| $250,000 to $499,999 | 2.75% | 2.25% | $12.92 |
| $500,000 to $999,999 | 1.95% | 1.75% | $12.81 |
| $1,000,000 to $5,000,000 | 0.00% | 1.00% | $12.56 |
The 12b-1 trail commission is 0.15% (accrues immediately) for all fixed-income and municipal income funds.
Class A shares purchased without a sales charge (commissionable NAV) will be subject to a CDSC of 1% if they are redeemed before the first day of the month in which the one-year anniversary of the purchase falls.
EXPENSE RATIOas of 12/31/2022
Fund Documents
Fund Documents
Download fund documents & literature, create email subscriptions, and place direct mail order
|
0Documents selected
|
Order | ||||
|---|---|---|---|---|---|
| n/a |
Portfolio Holdings 1Q
Publish Date:11/03/2015
|
||||
| n/a |
Portfolio Holdings 3Q
Publish Date:11/03/2015
|
||||
|
Summary Prospectus
Publish Date:11/03/2015
|
|||||
| n/a |
Statutory Prospectus
Publish Date:11/03/2015
|
||||
|
SAI
Publish Date:11/03/2015
|
|||||
|
Annual Report
Publish Date:11/03/2015
|
|||||
|
Semi-Annual Report
Publish Date:11/03/2015
|
|||||
|
Fact Sheet
Publish Date:11/03/2015
|
|||||